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Image-guided 31P magnetic resonance spectroscopy of normal and
transplanted human kidneys. Image-guided 31-phosphorus magnetic
resonance spectroscopy (MRS) was used to obtain spatially localized
31P spectra of good quality from healthy normal human kidneys and
from well-functioning renal allografts. A surface coil of 14 cm diameter
was used for acquiring phosphorus signals solely from a volume-
of-interest located within the kidney. To determine the effects of kidney
transplantation on renal metabolism, patients with well functioning
allografts were studied. Little or no phosphocreatine in all spectra
verifies the absence of muscle contamination, and is consistent with
proper volume localization. The intensity ratio of phosphomonoesters
(PME) to adenosine triphosphate (ATP) resonances in transplanted
kidneys (PME/ATP = 1.1 0.4) was slightly elevated (P 0.2)
compared to that of healthy normal kidneys (PME/ATP = 0.8 0.3).
The inorganic phosphate (Pi) to ATP ratio was similar in the two groups
(Pi/ATP = 1.1 0.1 in transplanted kidneys vs. 1.2 0.6 in normal
kidneys). Acid/base status, as evidenced from the chemical shift of Pi,
was the same in both normal controls and transplanted kidneys. Despite
the practical problems produced by organ depth, respiratory move-
ment, and tissue heterogeneity, these results demonstrate that image-
guided 31P MR spectra can reliably be obtained from human kidneys.
A high rate of oxidative phosphorylation in the kidney is
needed to maintain a stable concentration of adenosine triphos-
phate (ATP), which is used in part to provide the energy for the
solute reabsorption taking place in the renal tubules. Thus,
pathophysiological conditions which suppress oxidative phos-
phorylation, such as renal ischemia, may be associated with a
diminished concentration of ATP [1] and tissue acidosis [2]. The
method of 31P magnetic resonance spectroscopy (31P MRS)
enables non-invasive measurement of phosphorus metabolites
including ATP, inorganic phosphate (Pi), phosphodiesters
(PDE) including glycerophosphoryicholine and glycerophos-
phorylethanolamine, and phosphomonoesters (PME) including
phosphorylcholine and phosphorylethanolamine. Several re-
views concerning MRS studies of kidney metabolism in animals
have been recently published [3—6].
The use of 31P MRS to study renal metabolism was initiated
by Sehr et al [7] who obtained phosphorus signals from isolated
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kidneys in vitro. Subsequently, Ackerman et at [8] investigated
the effects of acute acidosis using the isolated, perfused kidney.
Weiner and colleagues [9 and literature cited therein] studied
high-energy phosphate metabolism of the intact kidney in situ
using implanted radio frequency coils, and found that acute
ischemia caused rapid disappearance of ATP [10] accompanied
by a rise of Pi. Siegel and coworkers [11] have studied the
effects of renal ischemia in situ using acutely implanted radio
frequency coils, and found that alterations of high-energy
phosphates correlated closely with recovery of renal function.
Balaban, Gadian and Radda [12] first measured renal 31P MRS
signals from an intact animal without implanted coils, using
topical magnetic resonance.
The availability of whole-body, high field magnets for mag-
netic resonance imaging (MRI), along with the recent develop-
ment of improved localization techniques [13—18] have permit-
ted MRS investigations of human brain, liver and heart
[reviewed in 19, 20]. However, the normal kidney has been a
particularly difficult organ for MRS studies for several reasons:
First, the kidney is at a greater distance from the surface of the
body than the previously studied organs, and a thick layer of
muscle lies between the body surface and the kidney. Second,
the kidney may move with respiration, making it difficult to
obtain MR spectra localized solely in the kidney during the long
spectral acquisition time. Finally, the presence of different
internal structures within the kidney (cortex, medulla, hilum)
complicates interpretation of spectra obtained from the entire
organ. Despite these problems, MRS studies of the human
kidney in situ are of potential importance because they are
expected to provide insight into the metabolic disturbances
associated with alterations of normal physiology, kidney dis-
ease, and renal transplantation.
The goal of the present experiments was to implement a
spatially localized technique so that 31P MR kidney spectra
could be routinely obtained without significant contamination
from surrounding tissues. Recent computer simulation studies
have indicated the ability of the ISIS localization method to
achieve satisfactory localization with surface coils [21]. In
addition, in preliminary MRS localization experiments we have
demonstrated our ability to obtain 31P spectra from normal
human kidney using ISIS [22]. Thus, the present studies were
initiated with a series of 31P MRS measurements on normal
human subjects. In order to determine the effects of kidney
294
Boska et a!: Image-guided 31P MRS of human kidneys 295
transplantation on renal metabolism, several patients with
well-functioning allografts were also studied.
Methods
Volunteers and patients
A total of 14 healthy volunteers (9 male, 5 female), 21 to 59
years of age, and 6 male patients, 24 to 67 years of age,
participated in the study. Only volunteers with no known
history of kidney disease, and whose scout MR images showed
no evidence of renal abnormalities, were selected. All patients
selected had kidney transplants functioning well for more than
one year as indicated by standard laboratory tests, and patients
showed no clinical evidence of urinary obstruction. In addition,
scout MR images obtained at the time of the MRS examination
showed no renal abnormalities. Spectra with a sufficient signal-
to-noise ratio (SIN) to reliably determine peak integrals were
obtained from seven volunteers and five transplant patients.
Kidney spectra from 10 volunteers and 6 transplant patients
were used to determine average chemical shifts of P metabo-
lites. The success rate with which spectra from normal kidneys
were obtained increased significantly with the introduction of
shim routines that allowed shimming localized solely on kidney
tissue. The study had prior approval from the UCSF Committee
of Human Research and informed consent was obtained from
every subject before examination.
Magnetic resonance instrumentation and measurements
31P MR spectra were obtained with a Philips Gyroscan
system operating at 2.0 Tesla (34.78 MHz for 31P) and equipped
with a spectroscopy package (Philips Medical Systems, The
Netherlands). Subjects were studied with the surface coil
placed underneath the kidney. In this position the surface coil
was orthogonal to the B, field of the imaging body coil, which
minimized RF interactions. A balanced matched [231, single-
turn surface coil of 14 cm diameter was used for transmitting
and receiving. A small glass vial containing 3 ml of hexameth-
ylphosphoroustriamide (HMPT, P[N(CH3)2]3), placed at the
center of the surface coil, served to identify coil position on the
locator MR image, and to calibrate the 31P RF field strength at
the center of the coil (so that the 900 pulse length at the center
of the VOl could be determined with computer-generated I
field plots [211). A similar glass vial containing tributoxyphos-
phine [TBP, P(0C4H9)31, which resonates 16 ppm downfield
from HMPT, was placed next to the HMPT vial to aid in the
determination of phasing parameters for 31P spectra.
Examination procedure. Normal subjects were positioned
supine, and transplant patients positioned prone, with the
kidney centered over the surface coil. A gap of about 1 cm was
maintained between the surface coil and the subject's skin.
Proton MR images were obtained using a Philips body coil.
Standard spin echo imaging techniques were employed without
respiratory gating to obtain scout (locator) images. A Gordon-
Timms arrangement [24] for double tuning the surface coil to
the proton frequency was used for shimming the magnet on the
'H signal of the tissue water. With a DEPTH-pulse shim
sequence [25], optimized to suppress muscle and fat signal from
tissue close to the coil, water linewidths of 20 to 35 Hz were
achieved routinely in 5 to 15 minutes. For some studies a
stimulated echo technique (STEVE) [26] was used to shim on
the VOl used for the 31P ISIS acquisition. This technique
yielded typical linewidths of 10 Hz. The frequency was then
switched to 34.78 MHz for 31P (with the carrier placed between
the HMPT and TBP resonances at Ca. 137 ppm downfield from
y-ATP) and the 180° pulse length of the HMPT phantom was
determined (between 100 and 180 ps). From this calibration the
90° plus length at the center of the VOl was calculated (between
140 and 200 s) using computer simulated B, isocontours of the
surface coil [21]. A one-pulse, fully relaxed spectrum of the
HMPT and TBP samples was stored for determination of zero
and first order phasing parameters. The proton images were
used to determine: 1) the coordinates of the VOl with respect to
the isocenter of the magnet; 2) the position of the VOl with
respect to the surface coil, usually centered about 50 mm from
the surface coil for transplanted kidney and 70 mm for normal
kidney studies; and 3) the volume of the VOl. usually between
30 and 60 ml. 31P spectra were then acquired with the carrier
placed between the y-ATP and PDE resonances. A modified
ISIS localization technique was used to reduce acquisition of
signal from outside the VOl produced by rapid signal averaging
[21, 22]. The following acquisition parameters were used: pulse
repetition time (TR) = 2 s, data size = 512 points, spectral
width = 3000 Hz, number of signal averages = 600 to 2700.
Data analysis
Spectral data were processed using the NMR1 software
package (New Methods Research, Inc., New York, USA) on a
VAX 11/730 and SUN 3/110. To obtain reliable integration of
the peak areas, the broad spectral component that underlies
narrower metabolite peaks was removed by convolution differ-
ence. (The broad spectral component is due to less mobile
phospholipids, bound phosphorus compounds and, possibly,
paramagnetically broadened components.) The raw FID was
multiplied with an exponential line-broadening factor of 300 Hz
which corresponded roughly to the linewidth-at-half-height of
the broad component in our experiments. Eighty percent of this
spectral component was then subtracted from the raw FID to
give FID = FID' x (1 — 0.8 exp (—300 irt)). FID' was then
multiplied with an exponential line-broadening factor of 20 Hz,
zero-filled to 1K data size and Fourier transformed.
Phasing. Correct phasing of low S/N spectra is critical for
peak integration, but is operator dependent. Therefore, in the
present experiments a one-pulse spectrum obtained from the
HMPT and TBP standards was not only used to calibrate pulse
power, but also to determine phase parameters for spectra
obtained from human kidneys. The high SIN of such a one-pulse
spectrum (typically around 50) allowed precise determination of
phasing parameters. Employment of these phasing standards
made phasing reproducible and independent of operator bias. In
vivo spectra obtained this way usually showed a flat baseline
after application of the convolution difference and were taken
as input for the curve fit routine which provided automatic
signal integration.
Signal integration. Figure 1 demonstrates the iterative curve
fitting routine of NMR1 used to integrate the six major metab-
olite peaks in a typical kidney transplant spectrum. Figure 1A
shows the difference between the experimental and computer
generated spectra. Figure lB displays the original baseline
flattened spectrum. Figure lC is a computer generated spec-
trum; it is displayed deconvoluted into its individual Gaussian







Fig. 1. Result of spectral curve fitting and integration. A. Difference
between the actual data and the calculated fit; B. spectrum obtained
from a transplanted human kidney; C. NMRI fit to the entire spectrum;
D. deconvolution of the individual peaks in the spectrum which was
used for integration of the individual spectral components.
signal components in Figure 1D. These components were
integrated individually 5 linewidths around their resonance
frequency. The difference spectrum in Figure 1A demonstrates
the good spectral fit. The y-ATP peak area was used for
deriving metabolite ratios containing ATP with the premise that
ADP in kidney is undetectable by MRS [27]. The a-ATP peak
area contains contributions from nicotinamide adenine dinucle-
otides (such as, NAD, NADH and their phosphates). The
13-ATP peak intensity was not used to derive ratios as it was
decreased significantly in these surface coil ISIS experiments
due to the "chemical shift offset effect" [for a discussion of this
effect see ref. 21 and 28].
Chemical shift. Chemical shifts are reported relative to
cs-ATP at —7.66 ppm. Reported values in ppm are derived from
curve-fitted spectra.
Statistical analysis
Statistical significance of the results was determined by use of
the unpaired t-test. A P-value of less than 0.05 was considered
significant. Values are expressed as mean SD.
Results
'H MRJ of normal and transplanted human kidneys
Figure 2 shows spin echo MR images obtained without
respiratory gating from 10 mm thick slices with the whole body
MRI coil. These scout images were used to locate the kidneys
and define the coordinates for the VOl from which 31P spectra
were acquired. The overall image quality, particularly the sharp
outline, indicates relatively little respiratory motion of the
kidneys. Nevertheless, cortico-medullary differentiation [29] is
poor. Figure 2A shows the two normal kidneys of a 59-year-old
male volunteer. Figure 2B shows a MR image of a 52-year-old
male with a renal transplant (subject #2) whose laboratory tests
indicated a well functioning allograft. On both Figures 2A and
2B the rectangular boxes indicate the anatomical region from
which the 31P MR spectra were obtained (ISIS VOl). While
each MR image depicts a single 10 mm thick slice through the
center of the ISIS VOI, the total VOl extends typically over 35
to 50 mm. The boxes indicate a nominal VOl; the acquired 31P
signals actually originate from a slightly larger volume than
indicated by the nominal ISIS box [21].
"P MRS of normal and transplanted human kidneys
Figure 3A shows a typical 31P MRS spectrum of a normal
kidney obtained with the ISIS localization technique with a one
hour acquisition time. Six major peaks were detected including
phosphomonoesters (PME), inorganic phosphate (Pi), phos-
phodiesters (PDE), and the y-, a-, and 13-resonances of adeno-
sine triphosphate. The peak labelled PDE may also contain
some signal contribution from phosphate in urine [30]. How-
ever, in contrast to animal kidneys [30], none of the kidney
spectra showed a discernable narrow peak in the PDE region
typical for urinary Pi. Only a very small peak for phosphocre-
atine (PCr) can be seen, indicating lack of significant contami-
nation of signal from surrounding skeletal or smooth muscle.
The 13-ATP resonance is significantly smaller than the y ATP
resonance; this is due to the "chemical shift offset effect" in
which the VOl for the fl-ATP is shifted slightly further from the
coil than the other resonances [21, 28]. The SIN ratio measured
on Pi is 7.5, while SIN in the analyzed normal kidney spectra
varied between 4.5 and 9 (mean 6.5, N = 7).
Figure 3B shows the 31P ISIS spectrum obtained in a one
hour acquisition time from the renal allograft depicted in Figure
2B. Peaks for the same six resonances seen in the normal
kidney are visible. Almost no PCr is detected. The height of the
PME peak is greater than that seen in the normal kidney.
Similar to the normal kidney, the J3-ATP peak is smaller than
the cx- or y-ATP peaks, due to the "chemical shift offset effect".
The S/N measured on Pi is 9.1, while S/N in the analyzed
kidney transplant spectra varied between 4.6 and 10.5 (mean
6.5, N = 5).
Table 1 shows the clinical and MRS data from each of the
kidney transplant patients studied. The PME/ATP and P1IATP
ratios are shown for each patient. There was no correlation
between these MRS data and blood urea nitrogen (BUN),
creatinine, blood pressure, or medication. The average PME/
ATP ratio of the normal kidneys was 0.8 0.3. The PMEIATP
ratio of the transplanted kidneys (1.1 0.4) was slightly
increased compared to normal kidneys, though the increase was
not statistically significant (P = 0.244). The Pi/ATP ratio of the
normal kidneys was 1.2 0.6, compared to 1.1 0.1 in the
transplanted kidneys. The PME/Pi and PDE/ATP ratios were
not significantly different between the two groups.
Chemical shifts in ppm for the major metabolites in 10 normal
kidneys measured relative to a-ATP at —7.66 ppm were: PME
6.69 0.15, Pi 5.25 0.26, PDE (including any possible urinary
N) 2.80 0.45, .ATP —2.39 0.18, 3-ATP —16.00 0.14
(mean SD). These values were not signfficantly different from
values obtained from the six kidney transplants. N chemical
shift in transplants was also 5.25 0.14 ppm. Absolute renal pH
was not calculated from the Pi chemical shift due to the lack of
a suitable chemical shift reference or titration curve. The water
resonance in renal tissue was not used as internal chemical shift
Discussion
Researchers in several laboratories have been performing
image-guided 31P MRS studies of human organs over the past
several years [28, 32—38]. In this laboratory we have been using
MR localization techniques routinely to obtain 31P MR spectra
from human muscle [351, brain [35, 36], liver [22, 28, 37], and
heart [22, 38]. However, the only 31P spectra of normal human
kidneys reported thus far are a single spectrum by Jue et a! [39]
and an ISIS spectrum obtained previously in this laboratory
[22]. 31P spectra from well functioning renal allografts were
previously reported in an abstract [40] using 31P DRESS local-
ratory movement have greatly hampered acquisition of spectra
from normal kidneys without substantial contamination of
signal from surrounding muscle. Initial studies of normal kid-
neys in this laboratory were not very successful because of
these problems and because of difficulties shimming over the
kidney volume. Recently, our ability to obtain kidney spectra
improved, largely because of two reasons: First, minimization
of kidney respiratory movement by supine positioning of nor-
mal controls; second, the ability to perform shimming localized
with stimulated echo techniques [26].
This report describes the first 31P MRS study of the metabolic
characteristics of healthy normal and transplanted kidneys in
human subjects. The present results demonstrate that 31P MR
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Fig. 2. A. Locator MR scout imageof healthy normal human kidneys. Acquisition parameters: TR = 450 ms, TB = 30 ms, FOV = 400 mm, slice
thickness = 10 mm, 1 measurement. The outlined box indicates the region of interest selected for spectral acquisition. B. Locator MR scout image
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Fig. 3. 31P ISIS spectra of the healthy normal kidney (A) seen in Figure 2A, and of the well functioning kidney transplant (B) shown in Figure 2B.
Acquisition parameters: TR = 2.0 s, acquisition time = I hr, 90 degree pulse set for the region of interest, distance of the center of VOl from 14
cm surface coil = 70 mm for normal kidney and 42 mm for transplanted kidney, size of the VOl 25 x 45 x 55 mm = 62 ml for normal kidney and
25 x 50 x 54 mm = 68 ml for transplanted kidney.
reference [31] because of the presence of residual eddy currents ization techniques. The depth of the normal kidney and respi-
in the ISIS experiment which could lead to frequency shifts.
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PME/ATP PiIATPPatient no. mg/dl mg/day
1 21 1.3 132/90 350 10 — 1.7 1.2
2 40 2.0 150/90 80 10 75 0.8 1.0
3 14 1.3 125/80 275 10 — 1.5 1.0
4 21 1.9 167/70 100 7.5 50 0.7 1.2
5 21 2.3 130/80 325 10 75 0.7 0.9
a normal range: 10 to 24b normal range: 0.6 to 1.4
whole blood HPLC method
Table 2. Metabolite ratios and Pi chemical shift (h) in normal and




PME/ATP 0.8 0.3 1.1 0.4
Pi/ATP 1.2 0.6 1.1 0.1
PME/Pi 0.9 0.6 1.0 0.3
PDE/ATP 2.6 1.2 1.8 0.7
[ppm] 5.25 0.26a 5.25
N = 10
bN 6
spectra with adequate S/N and resolution can be regularly
obtained from normal human kidneys. Signal-to-noise per unit
time, however, is reduced compared to that of kidney trans-
plant spectra, because normal kidneys are usually located
deeper inside the body than allografts, and thus further away
from the receiver surface coil. However, spectra obtained in
this study from normal kidneys show little or no signal from
phosphocreatine, demonstrating that the spectra are not signif-
icantly contaminated by signal from surrounding skeletal mus-
cle or smooth muscle of the intestines, and indicating that the
spectra represent renal tissue.
The spectra obtained from normal human subjects and trans-
plant recipients are very similar to those previously reported
from animal kidneys using a variety of techniques [41, 42]. In
comparison to other normal tissues, except for brain [36],
normal kidneys showed relatively large peaks for PME. The
PME/ATP ratio for normal kidney was 0.8, while PME/ATP
was 0.3 in liver [37] and <0.1 in muscle [35]. Based on
chemical shift (6.69 0.15 ppm) this high PME peak probably
represents phosphorylethanolamine [3], which is the major
component of the PME peak in other tissues [36, 37, 43]. It was
previously demonstrated that the relatively narrow resonance
signal from phosphate in tubular fluid in the renal pelvis
overlaps with the PDE peak [30, 44—46]. A significant contribu-
tion of urinary Pi to the PDE resonance is expected with any
degree of urinary obstruction, causing dilatation of the calyces
with a concomitant increase in amount of urine within the
measured volume. However, in this study there was no clinical
or MRI evidence of obstruction in any of the studied subjects,
and no discernable narrow peak in the PDE region, character-
istic for urinary Pi, was observed. Therefore, the broad PDE
peak is most likely composed of glycerophosphorylcholine and
glycerophosphorylethanolamine.
The PME/ATP ratio in renal transplants was slightly higher
than in healthy normal kidneys, although this difference was not
statistically significant. However, we note that previous studies
of transplanted kidneys in rats have shown elevated PME/ATP
ratios in rejecting kidneys [41].
The Pi/ATP in the well-functioning renal transplants studied
was comparable to that in normal kidneys, and similar to that
found in well-functioning rat kidney allografts [41]. However, in
the rat, rejection was associated with an increased PIIATP ratio,
possibly due to ischemia [41], An increased PIIATP ratio in
human transplants might also suggest renal ischemia due to
rejection or effects of cyclosporin A [41, 42].
There are a number of problems associated with 31P MRS of
the normal and transplanted human kidney. Most of these
problems relate to the low sensitivity of the experiment in part
due to the relatively small renal tissue volume and the depth of
the kidney from the surface. It is for these reasons that spectra
from renal transplants can be obtained with higher S/N than
spectra from normal kidneys. This low sensitivity of the exper-
iment limited the number of successful studies to only 7 out of
14 normal subjects, and it necessitated a minimum acquisition
time of 30 minutes for normal kidneys. Low S/N also prevented
acquisition of spectra from specific zones of the kidney, such as
renal cortex and medulla. The localized 31P spectra obtained in
this study consist of signals from primarily medulla and cortex,
even though the nominal ISIS volume depicted in Figure 2 is
centered over the renal pelvis. Blood and urine occupy a small
percentage of the true ISIS volume and contain low concentra-
tions of phosphorylated metabolites; therefore it is probable
that they did not contribute significantly to 31P spectra. Despite
the fact that spectra were obtained from heterogeneous tissue,
we think that spectra obtained from normal and transplanted
kidneys can be compared because all ISIS VOl's are similarly
composed of the three renal structures. Because of the proba-
bility that the Pi peak originates from inorganic phosphate in
different compartments [3] we do not calculate intrarenal pH.
However, it is noteworthy that the mean Pi chemical shift is the
same in both normal and transplanted kidney (5.25 ppm), while
the relatively large standard deviation (± 0.14 and 0.26 ppm)
may indicate signal heterogeneity. As more sensitive tech-
niques are developed, and higher-field magnets come into use,
31P MRS may ultimately detect localized signals from specific
zones of the kidney.
These findings demonstrate the feasibility of performing
localized magnetic resonance spectroscopy of the human kid-
ney, and suggest that there are no significant differences be-
tween metabolite ratios of normal kidneys and well-functioning
kidney transplants, if spectra are obtained from the whole
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kidney. Furthermore, these findings suggest that the non-
invasive MRS technique may be used to assess alterations of
overall renal pH in various acid-base disturbances [46, 47] and
changes in renal ATP associated with ischemic renal failure as
observed in previous animal studies [9, II, 12]. The present
finding that renal transplants may have slightly increased PME
raises the possibility that 31P MRS may be useful to assess
changes in renal metabolism associated with transplantation.
Future studies will be aimed at improving spatial resolution to
obtain spectra from different regions of the kidney and at
determining the effects of rejection and cyclosporine nephro-
toxicity on renal metabolism. In addition to 'P MR spectra,
investigators have obtained 'H metabolite spectra of other
human organs using water suppression techniques [for exam-
ple, 48—50] and also natural abundance 31C spectra [such as,
51]; in principle these methods could also be applied to kidney.
Ultimately, the information obtained from localized MRS stud-
ies of the human kidney may provide additional insights into
alterations of renal metabolism associated with physiological
maneuvers and the effects of disease.
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